Oktober 2021: Cabozantinib (Cabometyx, Exelixis, Inc.) er blevet godkendt af Food and Drug Administration til voksne og pædiatriske patienter på 12 år og ældre, som har lokalt fremskreden eller metastatisk differentieret skjoldbruskkirtel.
Lenvatinib (Lenvima) New oral anticancer drug Lenvima (lenvatinib) has recently been approved by Japan for the treatment of unresectable thyroid cancer. This is another important market that the drug has captured since it was app..